Table 1. Patient characteristics
Characteristics
No. of evaluable patients 117
Age, years
   Median 62
   Range 33–89
Median overall survival,* months 45
FIGO stage
   1A 4 (4)
   1C 1 (1)
   IIB 2 (2)
   IIC 5 (4)
   IIIA 1 (1)
   IIIB 3 (3)
   IIIC 87 (74)
   IV 12 (10)
   Missing 1 (1)
Histological type
   Papillary serous 91 (78)
   Clear cell 6 (5)
   Endometroid 4 (3)
   Mucinous 4 (3)
   Others (e.g., transitional, mixed) 12 (10)
Grade
   1 8 (7)
   2 4 (3)
   3 105 (90)
Response to frontline therapy
   Complete response 56 (48)
   Partial response 57 (49)
   Progression 3 (3)
   Unknown 1 (1)
Residual tumor
   None 55 (47)
   Present 56 (48)
   Unknown 6 (5)
Status
   Alive with no evidence of disease 26 (22)
   Alive with disease 31 (27)
   Dead of disease 58 (50)
   Dead with disease 1 (1)
   Dead with unknown disease status 1 (1)
CT antigen expression
   NY-ESO-1 50 (43)
   MAGE-A1 18 (15)
   MAGE-A4 13 (11)
  • Data in parentheses are percentages.

  • * C.I. = 33–58 months